Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06430697
Other study ID # 22-AOI-13
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date April 2027

Study information

Verified date May 2024
Source Centre Hospitalier Universitaire de Nice
Contact Kamila BURDZENIDZE, Study nurse
Phone 04 92 03 92 20
Email crc@chu-nice.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Paracetamol is commonly used in case of pain or fever. Few previously clinical studies has highlighted an arterial hypotension linked to intravenous administration of paracetamol. Currently, fewer data are available on the link of intravenous administration of paracetamol and effects on arterial tension. The aim of this study is to describe the frequency of occurrence of significative arterial hypotension within one hour following intravenous or per os administration of paracetamol . Other factors who can be associated to occurence of significative arterial hypotension will be also observe (for example age, weight, pain, vasopressor dosage or sedative...)


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date April 2027
Est. primary completion date December 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Inclusion: - 18 years of age or older - Patient with arterial catheter - Indication of paracetamol's administration by the patient's attending practitioner. - No opposition to patient or support person participation in the study if the patient is unable to participate ExclusionCriteria: - No Social Security Patient - Pregnant or nursing patient. - Patient with a legal protection measure - Hypersensitivity and/or allergy to paracetamol. - Contraindication to the use of paracetamol. - Patient opposition to health data collection.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
paracetamol administration
Patient hospitalized in Intensive Care Unit with a continuous measurement of blood pressure with a catheter and who have an administration of paracetamol by intravenous or per os

Locations

Country Name City State
France CHU de NICE ARCHET Nice

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure frequency of low blood pressure following paracetamol administration Proportion of patients with clinically significant low blood pressure occurring within one hour of administration of paracetamol IV or per os. Clinically significant low blood pressure is defined as an average blood pressure of less than 60 mmHg and/or a decrease in average blood pressure of more than 15%, and/or need for vascular filling and/or initiation or increase of the dose of noradrenaline One hour after administration of paracetamol
Secondary Measure of blood pressure following paracetamol administration according to IGS II score Identify patients' predictors of low blood pressure following paracetamol administration : Patients' will be identified by measuring frequency of patients with low blood pressure following paracetamol administration, according to The IGS II score (Simplified Severity Index II) is a score used to assess the severity of a patient and is one of the scores used in intensive care and SOFA score.
Components: The IGS II includes several variables, such as age, chronic health conditions, vital signs, and laboratory values. These factors are combined to calculate a numerical score.
Scoring: The higher the IGS II score, the greater the predicted risk of mortality. The score ranges from 0 to 100, with higher values indicating more severe illness.
One hour after administration of paracetamol
Secondary identify predictors linked to paracetamol administration route Measure of blood pressure to identify predictors by measuring frequency of patients with low blood pressure following paracetamol administration, according to administration's route One hour after administration of paracetamol
Secondary identify predictors linked to paracetamol dosage Measure of blood pressure to identify predictors by measuring frequency of patients with low blood pressure following paracetamol administration, according to dosage One hour after administration of paracetamol
Secondary Measure of blood pressure following paracetamol administration according to SOFA score Identify patients' predictors of low blood pressure following paracetamol administration : Patients' will be identified by measuring frequency of patients with low blood pressure following paracetamol administration, according to the SOFA score.
The sequential organ failure assessment score (SOFA score), previously known as the sepsis-related organ failure assessment score,is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure.
Each system is assigned a point value from 0 (normal) to 4 (high degree of dysfunction/failure). The worst physiological variables are collected serially every 24 hours of a patient's ICU admission12. The total SOFA score ranges from 0 (best) to 24 (worst) points. It's a valuable tool for predicting clinical outcomes in critically ill patients
One hour after administration of paracetamol
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06277518 - System for Postoperative Admission to ICU for Patients With Digestive System Malignancy
Completed NCT06251791 - Inspiratory Muscle Training and Expiratory Muscle Thickness N/A
Not yet recruiting NCT03247062 - Sleep Bundle for Improving Sleep in ICU Patients N/A
Completed NCT04110509 - Fragility and Programmed Cardiovascular Surgery (EcoSarco)
Recruiting NCT05587595 - Transition From Paediatric Intensive Care to General Paediatrics and Pneumology Units : a Study of the Post-intensive Care Syndrome
Active, not recruiting NCT05299346 - Post-ICU Follow-up Study in Covid-19 Patients
Recruiting NCT04112420 - Detection of the Incidence of Pre-existing Cardio-pulmonary Diseases by Using of Echocardiography N/A
Recruiting NCT05491590 - Patient-reported Outcome After Status Epilepticus
Recruiting NCT05155150 - Improving Shared-Decision Making in the Intensive Care Unit Using Patient-reported Outcome Information N/A
Completed NCT03642249 - Education for Recognition and Management of Delirium N/A
Withdrawn NCT03138278 - Impact on Family or Care-givers of Very Old ICU-survivors, Trajectories and 6 Months' Outcome in the Very Old. N/A
Completed NCT02784574 - Post ICU Follow up: A Questionnaire Survey of Aftercare in Denmark N/A
Completed NCT04412980 - Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD
Completed NCT04378504 - In Hospital Course of Acute Coronary Artery Syndromes
Completed NCT03124342 - Vanderbilt ICU Recovery Program Pilot Trial N/A
Completed NCT03457376 - Correlation of the Hand Grip Force With Maximum Inspiratory and Maximum Expiratory Pressure, in Critical Ill Patients N/A
Completed NCT03885687 - Exercise With Music for ICU Survivors N/A
Completed NCT03828552 - Parents' Experience of Their Children Stay in a Pediatric Intensive Care Unit.
Completed NCT03392857 - End Of Life in the Critically Ill patiEnt
Recruiting NCT05795569 - Removal of Nasogastric Feeding Tube Post Extubation in ICU : a Prospective Randomized Trial N/A